Back to search

National and Kapodistrian University of Athens

Σχεδιασμός και σύνθεση ενώσεων με αντικαρκινική δράση

Abstract

dc:description

This dissertation presents the design, synthesis and pharmacological evaluation of derivatives with potent anticancer activity. This derivatives belong to two main categories, acridines and quinazolines.Part A presents the acridine derivatives. Chapter 1 presents the actions of acridines in general and mentions their characteristic active derivatives with antibacterial, antiparasitic, phototherapeutic, anti-cancer action and action against neurodegenerative diseases.Chapter 2 presents the derivatives with activity against topoisomerases 1, 2 and Tyrosyl-DNA phosphodiesterases 1,2 as well as the novel ones with potent activity against these enzymes. Taking into account the synergistic effect of topoisomerases with Tyrosyl-DNA Phosphodiesterases, as well as the remarkable action of azaacridine derivatives bearing amino-substituted chains at positions 1.4 and methoxy group at position 8, the new ones were designed. In these derivatives for the study of the structure relationhisps, the length of the chains has been increased as well as the introduction of nitrogen or oxygen atoms. In addition, aliphatic chains have been replaced by cyclic and aromatic ones. Also the methoxy group at position 8, has been replaced by ethoxy, bromine, trifluoromethyl and phenyl substituted group. Finally, derivatives bearing hydrogen at position 8 and a bromιne at position 6 of the azaacridine backbone were designed in order to study this position.Chapter 3 presents the derivatives with potent action against RNA Polymerase I. Deregulation-inactivation of RNA polymerase I can lead to cancer, so it is necessary to find inhibitors. The novel derivatives were designed using BMH-21 and its derivatives that acted against RNA Polymerase 1 as lead compounds. The novel derivatives bearing the aza-acridine backbone have a chlorine in position 1, and in position 4 have a dimethylamino and diethylamino chain, a long chain containing oxyxone and hydroxyl, a chain with methyl substituted piperazine and a chain with ethoxypexide. Also in position 8 they have either hydrogen or methoxy group. The new derivatives were pharmacologically evaluated against cancer cell lines and several of them showed remarkable activity.Part B presents the quinazoline derivatives. Chapter 4 presents the general effects of quinazolines and mentions their characteristic active derivatives with antibacterial, antimalarial, antiviral, antiparkinsonian and anti-cancer activity.Chapter 5 presents new quinazoline derivatives with potent activity against TDP1,2. These derivatives were designed based on the azaacridine derivatives of Chapter 2, which have nitro substitution at position 4. Taking into consideration the remarkable activity of these derivatives against topoisomerases 1, 2, the correlation of topoisomerases 1,2 and TDP the significant anti-cancer activity of quinazoline derivatives, one of their rings was removed, thus turning them into quinazoline derivatives. The removal of this ring was done in order to study the significance of this ring in the activity against TDP 1,2.Chapter 6 presents quinazoline derivatives with potent activity against MEK1 and MEK2 kinases. MEK1 and MEK2 kinases play an intermediate role in the signal transduction pathway that includes the Ras / Raf / MEK / ERK sequence. Abnormal regulation or overactivation of this pathway leads to the growth and metabolism of cancer cells. Because MEK1,2 kinases are the only substrates of ERK1,2, the need to find inhibitors is important in order to inhibit the function of the ERK pathway leading to carcinogenesis. The new derivatives were designed using PD98059 and its derivatives as lead compounds with inhibitory activity against MEK1 and MEK2 kinases as a guide. In the new derivatives the basic chromone backbone has been replaced by the quinazoline backbone and the chlorine has been removed from position 6 and the methoxyl has been moved from position 3 to position 2 of the side benzene thus removing the aniline group. Also the action-important amine side chains of position 8 were replaced by amides bearing either one or two methylene respectively. These chains include a methylamino group, a cyclopropylamino group and a hydroxyl to form hydrogen bonds. The side chain bearing two hydroxyls was also designed to simulate the corresponding one of the guide compounds which showed significant activity. A methylamino chain was also designed for structure-action relationships. These chains include a methylamino group, a cyclopropylamino group and a hydroxyl to form hydrogen bonds. The side chain bearing two hydroxyls was also designed to simulate the corresponding one of the guide compounds which showed significant activity. Chapter 7 presents quinazoline derivatives with potent activity against Tankyrases 1,2. These tancyrases belong to the poly-ADP-ribose polymerases (PARPs), which are a group of enzymes that play an important role in maintaining cellular function and integrity. As tancyrases are involved in many cancer-related cellular functions, such as telomere maintenance, the Wnt oncology pathway, mitosis, and DNA repair, it is important to find inhibitors. Among their inhibitors is the derivative XAV939, which is a lead compound for the synthesis of new derivatives. As a large number of quinazoline derivatives are active against tancyrases 1 and 2, the new derivatives bear the basic quinazoline backbone and also bear an amide chain at position 8 which is substituted with diol to form hydrogen bonds at position 4, phenyl and propyl group as well as a methyl substitution for the study of structure-action relationship. The new derivatives were pharmacologically evaluated against Tankyras 1, 2 and PARPs 1,2 and some of them showed significant activity.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Karelou, Maria
  • Καρέλου, Μαρία

Subjects

dc:subject × 23

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/52712

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Karelou, Maria; Καρέλου, Μαρία. Σχεδιασμός και σύνθεση ενώσεων με αντικαρκινική δράση. National and Kapodistrian University of Athens, 2022. http://hdl.handle.net/10442/hedi/52712